The invention relates to a compound of the formula (I) in which: - R1 represents, independently of each other, a halogen atom; an aliphatic hydrocarbon-based group optionally substituted and/or optionally interrupted by one or more oxygen or sulfur atoms; a nitro group; a cyano group; an amino group; a mono- or dialkylamino group; an alkylcarbonyl group; a carboxyl group; an alkylcarbonylamino group; an alkylsulfonyl group; - R2 represents, independently of each other, a cyano group; a hydroxyl group, an alkylcarbonyl group; a carboxyl group; an alkoxycarbonyl group; an unsubstituted amide group; or a linear or branched alkyl group substituted by a cyano, hydroxyl, carboxyl, alkoxycarbonyl or unsubstituted amide group; - i and j independently being 1 to 5, with the exclusion of the compound for which i and j = 1 and R1 = carboxyl and R2 = alkoxycarbonyl or R1 = CF3 and R2 = carboxyl, and also the pharmaceutically acceptable derivatives, salts, solvates and stereoisomers thereof, including mixtures thereof in all proportions.
该发明涉及以下式(I)的化合物:- R1分别表示卤素原子;一种基于脂肪烃的基团,该基团可以选择性地被一个或多个氧或
硫原子取代和/或中断;硝基团;
氰基团;
氨基团;一种单烷基或二烷基
氨基团;一种烷基羰基团;羧基团;一种烷基羰基
氨基团;一种烷基磺酰基团;- R2分别表示
氰基团;羟基团;烷基羰基团;羧基团;烷氧羰基团;未取代酰胺基团;或由
氰基、羟基、羧基、烷氧羰基或未取代酰胺基团取代的线性或支链烷基团;- i和j独立地为1到5,不包括当i和j = 1且R1 = 羧基和R2 = 烷氧羰基或R1 =
CF3和R2 = 羧基时的化合物,以及其药学上可接受的衍
生物、盐、溶剂合物和立体异构体,包括所有比例的混合物。